title: Seroconversion and avidity maturation of cytomegalovirus-specific IgG in D+/R- lung transplant patients receiving different prophylactic anti-viral regimens.
authors.forename: Heidrun
authors.initials: H
authors.lastname: Kerschner
authors.forename: Barbara
authors.initials: B
authors.lastname: Zweytick
authors.forename: Walter
authors.initials: W
authors.lastname: Klepetko
authors.forename: Theresia
authors.initials: T
authors.lastname: Popow-Kraupp
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Puchhammer-Stöckl
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D016040:Lung Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D014019:Tissue Donors; D014180:Transplantation; D000077562:Valganciclovir
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir